Reducing Plasma Glucose Effect of Cinnamon in Type 2 Diabetic Patients in the Municipality of Comasagua

Launched by UNIVERSIDAD DR. JOSÉ MATÍAS DELGADO · Oct 16, 2018

Keywords

ClinConnect Summary

The study will be conducted for 12 weeks (3 months) with 30 participants diagnosed with type 2 diabetes mellitus, whose only treatment for diabetes is metformin.

Both, intervention with Cinnamon (Cinnamomum verum) and wheat flour (placebo) will be encapsulated in titanium white capsules with 500 mg of powder, that will take place in agro-industry laboratories, and will be packed in glass bottles with a content of 56 capsules and a bag of silica gel.

The data of the probable participants will verified with their medical records in the Intermediate Communitarian Unit of Family Health of Com...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of Type 2 Diabetes mellitus.
• • Treated only with Metformin as unique treatment for diabetes.
• Exclusion Criteria:
• • Hypersensitivity or allergy reported to Cinnamomum spp. or Peruvian balm.
• • Ulcer of gastrointestinal location.
• • Chronic treatment with analgesics, antibiotics, estrogens, antineoplastics, antihypertensives of the beta-blocker type, anti-inflammatory, medications whose route of action is Gamma-Aminobutyric Acid and / or anticoagulants.
• • Under treatment with steroid and / or aspirin.
• • Subject that use alternative medicine treatments.
• • Women of childbearing age who do not use any contraceptive method.
• • Subjects subjected to surgical procedures in the 6 weeks prior to the beginning of the study.
• • Subjects who presented fasting glycemia levels greater than 400 mg/dL in the previous control.
• • Allergies to wheat and/or diagnosed with celiac disease.
• • Adverse Drug Reaction during the study.
• • Subjects whose treatment schedule changed during the study intervention.
• • Subjects that does not accept to be part of the study, decides to leave the study or does not have adherence to the treatment provided.